Delivery Order SPE2DB22D2211-SPE2DB24FMCJ9

Award Date 11/6/23
Potential Completion Date 11/7/23
Potential Value $1.2K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $11,833.77 firm fixed-price delivery order covers the supply of Ondansetron ODT 8 MG Tablets, a pharmaceutical product used to treat nausea and vomiting. The contract has an ultimate completion date of May 16, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award, valued at $8,321.36, is for the delivery of Ondansetron ODT 8 mg tablets to support medical supply needs. The contract is a Delivery Order issued under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December...
This federal contract award, valued at $5,439.57, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Ondansetron ODT 8 mg tablets in a 30-count package. This award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC serves as a primary vehicle...
This federal contract award, valued at $35,886.23, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4562985541 - Ondansetron ODT 4 MG Tablet 30S, a pharmaceutical product, with a completion date of December 5, 2023. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...
The U.S. Defense Logistics Agency (DLA) awarded a $7,500.96 delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of 4559291100 - Ondansetron ODT 4 mg Tablets. This delivery order was placed under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range of pharmaceutical products and medical...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to deliver 4,561,783,106 units of Ondansetron ODT 4 mg tablets. The $4,427.20 firm-fixed-price delivery order has an ultimate completion date of August 14, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical, which provides a comprehensive range of...
This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The $29,013.80 firm fixed-price delivery order covers the supply of 4,560,376,093 units of the pharmaceutical drug Ondansetron ODT 4 mg Tablet in 30-count packages. The contract has an ultimate completion date of March 27, 2023. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,816.93 delivery order is for the supply of Ondansetron ODT 4 mg tablets, with a completion date of September 21, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC enables the DLA to efficiently...
This is a federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $11,179.76, is a Firm Fixed Price Delivery Order for the supply of Ondansetron ODT 8 mg Tablets. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by Cencora, Inc. with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Cencora, Inc. to...
This is a federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of 4,560,616,544 units of Ondansetron ODT 4 mg tablets in 30-count packages. The award has a ceiling value of $1,902.33 and an ultimate completion date of April 18, 2023. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA, valued at up to...
  • SPE2DB22D2211
    Indefinite Delivery Contract
  • SPE2DB22D2211-SPE2DB24FMCJ9
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,153.42 firm fixed-price delivery order is for the supply of 4562730527 - Ondansetron ODT 8 mg Tablets, 30s. The contract has an ultimate completion date of November 7, 2023 and was awarded on November 6, 2022. This award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. The IDC serves as the primary vehicle for Cencora, Inc. to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This specific award did not utilize any set-aside designations.

Generated 5/12/25, 10:12 AM